furosemide has been researched along with fenoldopam in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (70.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bernardi, M; Caimmi, PP; Cordero, G; Degasperis, C; Fiume, C; Fregonara, M; Guani, S; Kapetanakis, E; Micalizzi, E; Pagani, L; Panella, M; Parodi, F | 1 |
Lepor, NE | 1 |
Biancofiore, G; Bindi, L; Della Rocca, G; Esposito, M; Filipponi, F; Meacci, L; Mosca, F; Romanelli, A; Urbani, L | 1 |
Coccia, C; Costa, MG; Marco, PD; Monaco, S; Pietropaoli, P; Pompei, L; Rocca, GD; Scudeller, L | 1 |
Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
Bugge, JF; Laake, JH | 1 |
Camphausen, CK; Haas, NA | 1 |
Briguori, C; Condorelli, G; Donnarumma, E; Fiore, D; Quintavalle, C | 1 |
3 review(s) available for furosemide and fenoldopam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A review of pharmacologic interventions to prevent contrast-induced nephropathy.
Topics: Acetylcysteine; Adenosine; Calcium Channel Blockers; Contrast Media; Creatinine; Fenoldopam; Furosemide; Hemodynamics; Humans; Kidney Diseases; Mannitol; Prostaglandins | 2003 |
Therapeutic strategies to prevent contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Calcium Channel Blockers; Contrast Media; Diuretics; Dopamine; Fenoldopam; Fluid Therapy; Furosemide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Treatment Outcome; Vasodilator Agents | 2013 |
3 trial(s) available for furosemide and fenoldopam
Article | Year |
---|---|
Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiopulmonary Bypass; Creatinine; Diuretics; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Fenoldopam; Florida; Furosemide; Humans; Intensive Care Units; Kidney; Kidney Diseases; Length of Stay; Male; Middle Aged; Potassium; Prospective Studies; Treatment Outcome; Urination | 2003 |
Use of fenoldopam to control renal dysfunction early after liver transplantation.
Topics: Adult; Antibodies, Monoclonal; Basiliximab; Creatinine; Cyclosporine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Female; Fenoldopam; Furosemide; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Diseases; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Recombinant Fusion Proteins | 2004 |
Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Blood Volume; Cyclosporine; Diuretics; Dopamine; Dopamine Agonists; Female; Fenoldopam; Furosemide; Hemodynamics; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Liver Transplantation; Male; Mannitol; Middle Aged; Monitoring, Intraoperative; Pilot Projects; Postoperative Complications; Urodynamics | 2004 |
4 other study(ies) available for furosemide and fenoldopam
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
Prevention of acute renal failure--first do no harm!
Topics: Acute Kidney Injury; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Diuretics; Diuretics, Osmotic; Dopamine; Fenoldopam; Furosemide; Humans; Mannitol; Postoperative Complications; Vasodilator Agents | 2006 |
Fenoldapam after pediatric cardiac surgery: what is conventional diuretic therapy?
Topics: Aminophylline; Diuretics; Dopamine Agonists; Drug Therapy, Combination; Fenoldopam; Furosemide; Heart Defects, Congenital; Humans; Infant, Newborn; Peritoneal Dialysis; Postoperative Care; Triiodothyronine; Water-Electrolyte Imbalance | 2006 |